{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:10Z","timestamp":1781650090405,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H29-nanchitou(nan)-ippan-008"],"award-info":[{"award-number":["H29-nanchitou(nan)-ippan-008"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007331","name":"Aichi Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The present study aimed to investigate associations between long-term renal function, whether IgG4-related tubulointerstitial nephritis (TIN) was diagnosed by renal biopsy at initial examination, chronic kidney disease (CKD) stage, and histological stage in patients with IgG4-related TIN.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study used a retrospective cohort design including almost all patients who underwent renal biopsy at Fujita Health University Hospital and Nagoya University or its affiliated hospitals in Aichi between April 2003 and March 2015 (<jats:italic>n<\/jats:italic>\u2009=\u20096977 renal biopsies). The primary outcome was longitudinal changes in eGFR. Main exposures were whether IgG4-related TIN was diagnosed by renal biopsy at the initial examination, CKD stage, and its histological stage. Linear mixed models were performed to examine associations.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 6977 samples, there were 24 patients (with 201 records due to repeated measures) with IgG4-related TIN (20 men, mean age, 68.7\u2009\u00b1\u20099.7\u2009years). They were followed up 6.6\u2009\u00b1\u20092.8\u2009years after the renal biopsy and underwent glucocorticoid treatment. We found significant increase in eGFR from the baseline to 2 and 6\u2009months after treatment initiation, which was maintained until 60\u2009months. Patients initially diagnosed with IgG4-related TIN had higher eGFR from the baseline (at the start of treatment) to 60\u2009months than those who were not. Compared with patients with CKD stage 3, patients with CKD stages 4 and 5 had lower eGFR at the baseline and other time points. Patients with histological stage B had comparatively lower eGFR at each point than stage A patients. Those mean differences of eGFR were stable from the baseline to 60\u2009months.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>After the treatment initiation, renal function rapidly improved and maintained for a long period, even with advanced CKD stage. We showed importance of early diagnosis of IgG4-related TIN in maintaining eGFR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-020-02320-x","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T10:02:58Z","timestamp":1604570578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term changes in renal function after treatment initiation and the importance of early diagnosis in maintaining renal function among IgG4-related tubulointerstitial nephritis patients in Japan"],"prefix":"10.1186","volume":"22","author":[{"given":"Haruna","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshiro","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijo","family":"Inaguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-890X","authenticated-orcid":false,"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2320_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"M Rheumatology","year":"2012","unstructured":"Rheumatology M, Ky AS. Comprehensive diagnostic criteria for IgG4-related disease ( IgG4-RD ), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"2320_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.humpath.2011.06.002","volume":"43","author":"Y Yamaguchi","year":"2012","unstructured":"Yamaguchi Y, Kanetsuna Y, Honda K, Yamanaka N, Kawano M, Nagata M, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536\u201349.","journal-title":"Hum Pathol"},{"key":"2320_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","volume":"90","author":"JH Stone","year":"2015","unstructured":"Stone JH, Brito-Zer\u00f3n P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc. 2015;90:927\u201339.","journal-title":"Mayo Clin Proc"},{"key":"2320_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732\u20138.","journal-title":"N Engl J Med"},{"key":"2320_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ki.2013.393","volume":"85","author":"T Saeki","year":"2013","unstructured":"Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2013;85:251\u20137.","journal-title":"Kidney Int"},{"key":"2320_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982\u20134.","journal-title":"J Gastroenterol"},{"key":"2320_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/03009740410006439","volume":"33","author":"M Yamamoto","year":"2004","unstructured":"Yamamoto M, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz\u2019s disease. Scand J Rheumatol. 2004;33:432\u20133.","journal-title":"Scand J Rheumatol"},{"key":"2320_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JKC, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392.","journal-title":"Mod Pathol"},{"key":"2320_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ki.2010.271","volume":"78","author":"T Saeki","year":"2010","unstructured":"Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016\u201323.","journal-title":"Kidney Int"},{"key":"2320_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","volume":"15","author":"M Kawano","year":"2011","unstructured":"Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615\u201326.","journal-title":"Clin Exp Nephrol"},{"key":"2320_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.2011010062","volume":"22","author":"Y Raissian","year":"2011","unstructured":"Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"2320_CR12","doi-asserted-by":"crossref","unstructured":"Nishi S, Imai N, Yoshida K, Ito Y, Saeki T. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol. 2011;15:810\u20139.","DOI":"10.1007\/s10157-011-0526-x"},{"key":"2320_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.semdp.2012.07.004","volume":"29","author":"LD Cornell","year":"2012","unstructured":"Cornell LD. IgG4-related kidney disease. Semin Diagn Pathol. 2012;29:245\u201350.","journal-title":"Semin Diagn Pathol"},{"key":"2320_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ki.2013.191","volume":"84","author":"T Saeki","year":"2013","unstructured":"Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int Nature Publishing Group. 2013;84:826\u201333.","journal-title":"Kidney Int Nature Publishing Group"},{"key":"2320_CR15","unstructured":"Nishi S, Imai N, Yoshida K, Ito Y, Saeki T. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin. Exp. Nephrol.2011;15:810\u2013819."},{"key":"2320_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3109\/s10165-011-0589-2","volume":"22","author":"I Mizushima","year":"2012","unstructured":"Mizushima I, Yamada K, Fujii H, Inoue D, Umehara H, Yamagishi M, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22:859\u201370.","journal-title":"Mod Rheumatol"},{"key":"2320_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00296-014-3153-5","volume":"35","author":"H Arai","year":"2015","unstructured":"Arai H, Hayashi H, Takahashi K, Koide S, Sato W, Hasegawa M, et al. Tubulointerstitial fibrosis in patients with IgG4-related kidney disease: pathological findings on repeat renal biopsy. Rheumatol Int. 2015;35:1093\u2013101.","journal-title":"Rheumatol Int"},{"key":"2320_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10157-015-1140-0","volume":"20","author":"T Saeki","year":"2016","unstructured":"Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Ubara Y, et al. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol Springer Tokyo. 2016;20:87\u201393.","journal-title":"Clin Exp Nephrol Springer Tokyo"},{"key":"2320_CR19","doi-asserted-by":"crossref","unstructured":"Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Sci Rep Nature. 2018;8.","DOI":"10.1038\/s41598-018-28405-x"},{"key":"2320_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis WB Saunders. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis WB Saunders"},{"key":"2320_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","volume":"20","author":"EF Schisterman","year":"2009","unstructured":"Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488\u201395.","journal-title":"Epidemiology."},{"key":"2320_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v078.i02","volume":"78","author":"C Proust-Lima","year":"2017","unstructured":"Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the {R} package {lcmm}. J Stat Softw. 2017;78:1\u201356.","journal-title":"J Stat Softw"},{"key":"2320_CR23","unstructured":"core Team R. R: a language and environment for statistical computing. R Found Stat Comput Vienna, Austria. 2018;."},{"key":"2320_CR24","doi-asserted-by":"crossref","unstructured":"Mizushima I, Yamamoto M, Inoue D, Nishi S, Taniguchi Y, Ubara Y, et al. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Arthritis Res Ther; 2016;18:1\u20139.","DOI":"10.1186\/s13075-016-1175-y"},{"key":"2320_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology."},{"key":"2320_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/ajg.2009.325","volume":"104","author":"A Raina","year":"2009","unstructured":"Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large us center. Am J Gastroenterol. 2009;104:2295\u2013306.","journal-title":"Am J Gastroenterol"},{"key":"2320_CR27","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Codina A, Mart\u00ednez-Valle F, Pinilla B, L\u00f3pez C, De Torres I, Solans-Laqu\u00e9 R, et al. IgG4-related disease: results from a multicenter Spanish registry. Med (United States). Lippincott Williams and Wilkins; 2015;94.","DOI":"10.1097\/MD.0000000000001275"},{"key":"2320_CR28","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u201315.","journal-title":"Gut."},{"key":"2320_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2320_CR30","doi-asserted-by":"publisher","first-page":"21337","DOI":"10.18632\/oncotarget.25095","volume":"9","author":"G Quattrocchio","year":"2018","unstructured":"Quattrocchio G, Barreca A, Demarchi A, Solfietti L, Beltrame G, Fenoglio R, et al. IgG4-related kidney disease: the effects of a rituximab-based immunosuppressive therapy. Oncotarget. 2018;9:21337\u201347.","journal-title":"Oncotarget."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-020-02320-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T02:08:45Z","timestamp":1604714925000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02320-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2320"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02320-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Fujita Health University and Nagoya University. The need for patient consent was waived due to the retrospective nature of the study and the absence of personally identifiable data in the report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}